[Federal Register Volume 81, Number 62 (Thursday, March 31, 2016)]
[Notices]
[Pages 18631-18632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-07225]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-16-1074]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Colorectal Cancer Control Program (CRCCP) Monitoring Activities
--Reinstatement with Change (OMB No. 0920-1074, exp. 12/31/2015)
--National Center for Chronic Disease Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
CDC is requesting a reinstatement with change of the information
collect project assigned OMB Control Number 0920-1074, formerly
entitled ``Annual Survey of Colorectal Cancer Control Activities
Conducted by States and Tribal Organizations.'' In the previous OMB
approval period, information collection consisted of an annual grantee
survey. In the next OMB approval period, information collection will
consist of a redesigned survey and a new clinic-level information
collection. The number of respondents will increase and the total
estimated annualized burden will increase.
Among cancers that affect both men and women, colorectal cancer
(CRC) is the second leading cause of death from cancer in the United
States. CRC screening has been shown to reduce incidence of and death
from the disease. Screening for CRC can detect disease early when
treatment is more effective and prevent cancer by finding and removing
precancerous polyps. Of individuals diagnosed with early stage CRC,
more than 90% live five or more years. Despite strong evidence
supporting screening, only 65% of adults currently report being up-to-
date with CRC screening as recommended by the U.S. Preventive Services
Task Force, with more than 22 million age-eligible adults estimated to
be untested. To reduce CRC morbidity, mortality, and associated costs,
use of CRC screening tests must be increased among age-eligible adults
with the lowest CRC screening rates.
CDC's Colorectal Cancer Control Program (CRCCP) currently provides
funding to 31 grantees under ``Organized Approaches to Increase
[[Page 18632]]
Colorectal Cancer Screening'' (CDC-RFA-DP15-1502). CRCCP grantees
include state governments or bona-fide agents, universities, and tribal
organizations. The purpose of the new cooperative agreement program is
to increase CRC screening rates among an applicant defined target
population of persons 50-75 years of age within a partner health system
serving a defined geographical area or disparate population.
The CRCCP was significantly redesigned in 2015 and has two
components. Under Component 1, all 31 CRCCP grantees receive funding to
support partnerships with health systems to implement up to four
priority evidence-based interventions (EBIs) described in the Guide to
Community Preventive Services, as well as other supporting strategies.
Grantees must implement at least two EBIs in each partnering health
system. Under Component 2, 6 of the 31 CRCCP grantees will provide
direct screening and follow-up clinical services for a limited number
of individuals aged 50-64 in the program's priority population who are
asymptomatic, at average risk for CRC, have inadequate or no health
insurance for CRC screening, and are low income.
Based on the redesigned CRCCP, the information collection plan has
also been redesigned to address the two program components. The new
cooperative agreement program (CDC-RFA-DP15-1502) requires that CDC
monitor and evaluate the CRCCP and individual grantee performance using
both process and outcome evaluation. Two forms are proposed. First, the
CRCCP grantee survey was redesigned to align with new CRCCP goals. The
grantee survey will be submitted to CDC annually. Second, CDC proposes
to collect clinic-level information to assess changes in CDC's primary
outcome of interest, i.e., CRC screening rates within partner health
systems. Each grantee will complete a clinic-level collection template
once per year. All information will be reported to CDC electronically.
The information collection will enable CDC to gauge progress in
meeting CRCCP program goals and to monitor implementation activities,
evaluate outcomes, and identify grantee technical assistance needs. In
addition, findings will inform program improvement and help identify
successful activities that need to be maintained, replicated, or
expanded.
OMB approval is requested for three years. Participation is
required for CRCCP awardees. In the pilot test for the CRCCP annual
grantee survey, the average time to complete the instrument was
approximately 45 minutes. In the pilot test for the CRCCP clinic-level
information collection, the average time to complete the instrument was
approximately 30 minutes. CDC estimates an average of 12 responses per
grantee annually to correspond with the number of health system
partners. The total estimated annualized burden hours are 209. There
are no costs to respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hr)
----------------------------------------------------------------------------------------------------------------
CRCCP Grantees........................ CRCCP Annual Grantee 31 1 45/60
Survey.
CRCCP Clinic-level 31 12 30/60
Information Collection
Template.
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2016-07225 Filed 3-30-16; 8:45 am]
BILLING CODE 4163-18-P